Summary of Classification and Labelling
Notified classification and labelling
General Information
EC / List no.
|
Name |
CAS Number
|
---|---|---|
642-915-3 | N-(3 chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2 (methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine bis(4 methylbenzenesulfonate) monohydrate | 388082-78-8 |
Notified classification and labelling according to CLP criteria
Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
Aquatic Chronic 4 | H413 | H413 |
State/Form
|
2 | View details | ||||||
Repr. 1B | H360 (H360D) | H360 (D) |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
Lact. | H362 | H362 | |||||||||
STOT RE 2 | H373 (other:unknown) | H373 (unkown) | |||||||||
Aquatic Chronic 4 | H413 | H413 | |||||||||
Repr. 1B | H360 | H360 |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
STOT RE 1 | H372 (Immune system) (oral) | H372 | |||||||||
H360 |
GHS01 Dgr |
State/Form
|
1 | View details | |||||||
STOT RE 1 | H372 (other:Liver, He...) | H372 | |||||||||
H413 | |||||||||||
Skin Irrit. 2 | H315 | H315 |
GHS07 GHS09 Wng |
State/Form
|
1 | View details | |||||
Eye Irrit. 2 | H319 | H319 | |||||||||
Aquatic Chronic 1 | H410 | H410 |
Number of Aggregated Notifications: 5